Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +8 vs. Q4 2021
- Shares held
- 13.2M
- +137.4K (+1.1%) vs. Q4 2021
- Total value
- $222.2M
- −$72.0M (−24.5%) vs. Q4 2021
- New holders
- 9
- 11 more added
- Sold out
- 1
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tucker Asset Management LLC | 4 | $67 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 39 | $656 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 44 | $1.00K | 0.00% | +44 | New |
| Spire Wealth Management | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 316 | $5.00K | 0.00% | −1,829−85.3% | Reduced |
| Ameritas Investment Partners, Inc. | 515 | $9.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 737 | $13.0K | 0.00% | −1,410−65.7% | Reduced |
| Legal & General Group Plc | 868 | $15.0K | 0.00% | +50+6.1% | Added |
| Amalgamated Bank | 1,306 | $22.0K | 0.00% | +1,306 | New |
| Amalgamated Financial Corp. | 1,306 | $22.0K | 0.00% | +1,306 | New |
| STRS Ohio | 2,100 | $35.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,593 | $44.0K | 0.00% | +2,593 | New |
| California State Teachers Retirement System | 3,615 | $61.0K | 0.00% | −1,025−22.1% | Reduced |
| JPMorgan Chase & Co | 3,954 | $67.0K | 0.00% | −170,782−97.7% | Reduced |
| American International Group, Inc. | 4,186 | $70.0K | 0.00% | −294−6.6% | Reduced |
| UBS Group AG | 4,226 | $71.0K | 0.00% | +1,142+37.0% | Added |
| Wells Fargo & Company | 4,713 | $79.0K | 0.00% | −2,941−38.4% | Reduced |
| Deutsche Bank AG | 4,726 | $79.0K | 0.00% | −961−16.9% | Reduced |
| New York State Common Retirement Fund | 5,881 | $99.0K | 0.00% | +9+0.2% | Added |
| Tower Research Capital LLC (TRC) | 6,424 | $108.0K | 0.00% | +5,772+885.3% | Added |
| Bank of America Corp | 6,499 | $109.0K | 0.00% | −4,163−39.0% | Reduced |
| J. Goldman & Co LP | 10,544 | $177.0K | 0.01% | +10,544 | New |
| Morgan Stanley | 11,211 | $188.0K | 0.00% | −27−0.2% | Reduced |
| Allspring Global Investments Holdings, LLC | 12,760 | $214.0K | 0.00% | −125−1.0% | Reduced |
| Nuveen Asset Management, LLC | 21,763 | $381.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,101 | $422.0K | 0.00% | +25,101 | New |
| Bank of New York Mellon Corp | 25,111 | $423.0K | 0.00% | −175−0.7% | Reduced |
| Invesco Ltd. | 27,982 | $471.0K | 0.00% | +4,078+17.1% | Added |
| Goldman Sachs Group Inc | 28,256 | $475.0K | 0.00% | +153+0.5% | Added |
| Dimensional Fund Advisors LP | 28,855 | $485.0K | 0.00% | +19,865+221.0% | Added |
| DLD Asset Management, LP | 32,500 | $547.0K | 0.04% | +32,500 | New |
| SG Americas Securities, LLC | 42,439 | $714.0K | 0.01% | −1,891−4.3% | Reduced |
| Charles Schwab Investment Management Inc | 48,583 | $818.0K | 0.00% | +1,402+3.0% | Added |
| Northern Trust Corp | 68,732 | $1.16M | 0.00% | −3,049−4.2% | Reduced |
| Ghost Tree Capital, LLC | 120,000 | $2.02M | 1.00% | −50,000−29.4% | Reduced |
| Geode Capital Management, LLC | 130,758 | $2.20M | 0.00% | +4,943+3.9% | Added |
| State Street Corp | 132,883 | $2.23M | 0.00% | +3,141+2.4% | Added |
| Ensign Peak Advisors, Inc | 242,451 | $4.08M | 0.01% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 260,000 | $4.37M | 0.91% | 00.0% | Unchanged |
| Tang Capital Management LLC | 300,000 | $5.05M | 1.02% | +300,000 | New |
| Jefferies Group LLC | 402,758 | $6.77M | 0.16% | −20,235−4.8% | Reduced |
| BlackRock Inc. | 439,958 | $7.40M | 0.00% | −9,000−2.0% | Reduced |
| Vanguard Group Inc | 458,816 | $7.72M | 0.00% | −374−0.1% | Reduced |
| Cowen and Company, LLC | 534,524 | $8.99M | 0.91% | +20,235+3.9% | Added |
| TimesSquare Capital Management, LLC | 659,600 | $11.1M | 0.12% | −1,200−0.2% | Reduced |
| Perceptive Advisors LLC | 1,296,416 | $21.8M | 0.45% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,375,982 | $23.1M | 1.78% | −27,349−1.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,417,157 | $23.8M | 2.03% | +1,417,157 | New |
| RTW Investments, LP | 2,013,601 | $33.9M | 0.70% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,987,331 | $50.2M | 3.46% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,417,157−100.0% | Sold out |